Author

José Oñate

Observed names: J Oñate, JORGE Oñate-Gutierrez JM, Jose Millan Onate, Jose Millan-Oñate, Jose Millan‐Oñate, Jose Millán Oñate, Jose Millán-Oñate, Jose Onate, Jose Oñate, Jose Oñate-Gutiérrez, José M. Oñate, José M. Oñate-Gutiérrez, José Millan Oñate, José Millán Oñate, José Millán Oñate Gutiérrez, José Millán-Oñate, Oñate, Jose

Institution: Universidad Santiago de Cali

Observed institutions: Mubende Hospital, Universidad Nacional de Colombia, Centro Internacional de Entrenamiento e Investigaciones Medicas, Universidad Santiago de Cali, Asociación Colombiana de Infectología, Lebanese American University, Universidad del Valle, University of Lausanne

ORCID: 0000-0002-6180-792X

Observed ORCID: 0000-0002-6180-792X

OpenAlex ID: A5075731663

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

2022 · Hongchao Pan, Richard Peto, et al. · The Lancet · 394

Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19

2021 · Eduardo López-Medina, Pío López, et al. · JAMA · 376

Dengue and COVID‐19, overlapping epidemics? An analysis from Colombia

2020 · Jaime A. Cardona‐Ospina, Kovy Arteaga‐Livias, et al. · Journal of Medical Virology · 134

A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19)

2020 · José Millán-Oñate, Alfonso J. Rodriguez-Morales, et al. · Infectio · 126

Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin

2020 · José Millán-Oñate, William Millan, et al. · Annals of Clinical Microbiology and Antimicrobials · 60

Plasmodium vivax Sporozoite Challenge in Malaria-Naïve and Semi-Immune Colombian Volunteers

2014 · Myriam Arévalo-Herrera, David A. Forero-Peña, et al. · PLoS ONE · 56

COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs

2021 · Alfonso J. Rodriguez-Morales, Ranjit Sah, et al. · Therapeutic Advances in Infectious Disease · 55

Protective Efficacy of Plasmodium vivax Radiation-Attenuated Sporozoites in Colombian Volunteers: A Randomized Controlled Trial

2016 · Myriam Arévalo-Herrera, Juan M. Vásquez-Jiménez, et al. · PLoS neglected tropical diseases · 50

Latin America: Situation and preparedness facing the multi-country human monkeypox outbreak

2022 · Alfonso J. Rodriguez-Morales, Alfonso J. Rodriguez-Morales, et al. · The Lancet Regional Health - Americas · 37

Epidemiology of Candida isolates from Intensive Care Units in Colombia from 2010 to 2013

2016 · Gabriel Motoa, Juan Sebastián Muñoz, et al. · Revista Iberoamericana de Micología · 35

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

2023 · Chloe Orkin, Jean-Michel Molina, et al. · The Lancet HIV · 34

The global challenges of the long COVID-19 in adults and children

2023 · Alfonso J. Rodriguez-Morales, María Camila Lopez-Echeverri, et al. · Travel Medicine and Infectious Disease · 29

Randomized clinical trial to assess the protective efficacy of a Plasmodium vivax CS synthetic vaccine

2022 · Myriam Arévalo-Herrera, Xiomara Gaitán, et al. · Nature Communications · 28

Delta variant of SARS-CoV-2: characteristics and implications for public health in Colombia

2021 · Nacy Yomayusa, Roman Vega, et al. · Revista de la Facultad de Medicina · 19

Increased mortality associated with uncontrolled diabetes mellitus in patients with pulmonary cryptococcosis: a single US cohort study

2021 · Solana Archuleta, Amal A. Gharamti, et al. · Therapeutic Advances in Infectious Disease · 17

Insuficiencia suprarrenal secundaria a paracoccidioidomicosis.

2002 · José M. Oñate, Angela María Tobón, et al. · Biomédica · 17

Colombian consensus on the diagnosis, treatment, and prevention of Candida Spp. disease in children and adults*,+

2019 · José M. Oñate, Pilar Rivas, et al. · Infectio · 16

Infectious diseases prevention and vaccination in migrants in Latin America: The challenges of transit through the treacherous Darien gap, Panama

2025 · Alfonso J. Rodriguez-Morales, María Camila Puerta-Arias, et al. · Travel Medicine and Infectious Disease · 15

HLA-B*57:01 allele prevalence in treatment-Naïve HIV-infected patients from Colombia

2019 · Ernesto Martínez Buitrago, José Millán Oñate, et al. · BMC Infectious Diseases · 14

Changing Climate, Changing Candida: Environmental and Social Pressures on Invasive Candidiasis and Antifungal Resistance in Latin America

2025 · Juan Camilo Motta, Pilar Rivas-Pinedo, et al. · Journal of Fungi · 9

Evaluación y manejo del riesgo cardiovascular en infección por VIH. Consenso de expertos ACIN

2018 · Sandra Liliana Valderrama Beltrán, Sandra Milena Gualtero, et al. · Infectio · 8

Prevalencia y factores relacionados con la infección por Clostridium difficile en un centro hospitalario de alta complejidad en Cali (Colombia)

2017 · José Millán Oñate Gutiérrez, María Virginia Villegas, et al. · Infectio · 8

Human T-cell Lymphotropic Virus Type I Associated with Amyotrophic Lateral Sclerosis Syndrome: Immunopathological Aspects and Treatment Options

2020 · Fernando Gonzalez Trujillo, Karen Parra Cortes, et al. · Cureus · 7

Consensus Recommendations Based on Evidence for Abdominal Sepsis in the Pediatric and Adult Population of Colombia

2021 · Jose Oñate, Christian José Pallares Gutiérrez, et al. · Infectio · 5

Guía de práctica clínica para el diagnóstico y tratamiento de la criptococosis en personas adultas que viven con el VIH

2024 · Jorge Alberto Cortés, Martha Carolina Valderrama-Rios, et al. · Infectio · 3

Works count: 51

Citation count: 1,576

H-index: 16

I10-index: 19